Amneal Pharmaceuticals has a market capitalization of US$1.7b, so we would expect some institutional investors to have noticed the stock. Our analysis of the ownership of the company, below, shows that institutions are noticeable on the share registry. Let's delve deeper into each type of owner, to discover more about Amneal Pharmaceuticals.